Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 344

1.

[Documentation Time and Effort and Associated Resources for Patients with Primary Breast Cancer from Diagnosis to End of Follow-Up - Results of a Multicentre Validation].

Beckmann M, Sell C, Aydogdu M, Brucker SY, Fehm T, Janni W, Kreienberg R, Kümmel S, Neumann M, Scharl A, Schleicher B, Wallwiener D, Wöckel A, Fasching PA, Lux MP.

Gesundheitswesen. 2015 Aug 6. [Epub ahead of print] German.

PMID:
26250614
2.

Breast Cancer Patients' Fear of Treatment: Results from the Multicenter Longitudinal Study BRENDA II.

Singer S, Blettner M, Kreienberg R, Janni W, Wöckel A, Kühn T, Felberbaum R, Flock F, Schwentner L; BRENDA II study group.

Breast Care (Basel). 2015 Apr;10(2):95-100. doi: 10.1159/000381933.

PMID:
26195937
3.

Guidelines are advantageous, though not essential for improved survival among breast cancer patients.

Wolters R, Wischhusen J, Stüber T, Weiss CR, Krockberger M, Bartmann C, Blettner M, Janni W, Kreienberg R, Schwentner L, Novopashenny I, Wischnewsky M, Wöckel A, Diessner J.

Breast Cancer Res Treat. 2015 Jul;152(2):357-66. doi: 10.1007/s10549-015-3484-2. Epub 2015 Jun 24.

PMID:
26105798
4.

Aggressive Intrinsic Subtypes in Breast Cancer: A Predictor of Guideline Adherence in Older Patients With Breast Cancer?

Ebner F, Hancke K, Blettner M, Schwentner L, Wöckel A, Kreienberg R, Janni W, van Ewijk R.

Clin Breast Cancer. 2015 Aug;15(4):e189-95. doi: 10.1016/j.clbc.2015.03.003. Epub 2015 Mar 23.

PMID:
25913904
5.

Identifying the impact of inflammatory breast cancer on survival: a retrospective multi-center cohort study.

Diessner J, Van Ewijk R, Weiss CR, Janni W, Wischnewsky MB, Kreienberg R, Hancke K, Blettner M, Wöckel A, Schwentner L.

Arch Gynecol Obstet. 2015 Sep;292(3):655-64. doi: 10.1007/s00404-015-3691-4. Epub 2015 Mar 27.

PMID:
25814296
6.

Tumor biology in older breast cancer patients--what is the impact on survival stratified for guideline adherence? A retrospective multi-centre cohort study of 5378 patients.

Ebner F, van Ewijk R, Wöckel A, Hancke K, Schwentner L, Fink V, Kreienberg R, Janni W, Blettner M.

Breast. 2015 Jun;24(3):256-62. doi: 10.1016/j.breast.2015.02.029. Epub 2015 Mar 11.

PMID:
25769974
7.

Predicting fatigue in older breast cancer patients receiving radiotherapy. A head-to-head comparison of established assessments.

Denkinger MD, Hasch M, Gerstmayer A, Kreienberg R, Nikolaus T, Hancke K.

Z Gerontol Geriatr. 2015 Feb;48(2):128-34. doi: 10.1007/s00391-014-0840-5. Epub 2015 Jan 16.

PMID:
25592175
8.

Does patient education work in breast cancer? Final results from the global CARIATIDE study.

Markopoulos C, Neven P, Tanner M, Marty M, Kreienberg R, Atkins L, Franquet A, Gnant M, Neciosup S, Tesarova P, Barni S, Deschamp V.

Future Oncol. 2015 Jan;11(2):205-17. doi: 10.2217/fon.14.179.

PMID:
25591836
9.

Radiotherapy effects on early breast cancer survival in observational and randomized studies: a systematic analysis of advantages, disadvantages and differences between the two study types.

König J, van Ewijk R, Kuhr K, Schmidberger H, Wöckel A, Kreienberg R, Blettner M.

Breast Cancer. 2015 Jan 14. [Epub ahead of print]

PMID:
25585654
10.

Quality of care in breast cancer centers: results of benchmarking by the German Cancer Society and German Society for Breast Diseases.

Kowalski C, Ferencz J, Brucker SY, Kreienberg R, Wesselmann S.

Breast. 2015 Apr;24(2):118-23. doi: 10.1016/j.breast.2014.11.014. Epub 2014 Dec 13.

PMID:
25515645
11.

Response to: Importance of work-life balance among German medical students who wish to become gynecologists.

Hancke K, Igl W, Toth B, Bühren A, Ditsch N, Kreienberg R.

Arch Gynecol Obstet. 2015 Feb;291(2):241. doi: 10.1007/s00404-014-3530-z. No abstract available.

PMID:
25384518
12.
13.

Concentration of gynaecology and obstetrics in Germany: is comprehensive access at stake?

Mennicken R, Kolodziej IW, Augurzky B, Kreienberg R.

Health Policy. 2014 Dec;118(3):396-406. doi: 10.1016/j.healthpol.2014.07.017. Epub 2014 Aug 2.

PMID:
25201487
14.

Is guideline-adherent adjuvant treatment an equal alternative for patients aged >65 who cannot participate in adjuvant clinical breast cancer trials? A retrospective multi-center cohort study of 4,142 patients.

Van Ewijk R, Wöckel A, Gundelach T, Hancke K, Janni W, Singer S, Kreienberg R, Blettner M, Schwentner L.

Arch Gynecol Obstet. 2015 Mar;291(3):631-40. doi: 10.1007/s00404-014-3438-7. Epub 2014 Sep 2.

PMID:
25178186
15.

DGGG Guidelines Programme: Status Quo - Quo Vadis!

Beckmann MW, Linde I, Bütof C, Kreienberg R, Gass P.

Geburtshilfe Frauenheilkd. 2014 Mar;74(3):251-259.

16.

Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression.

Nitz U, Gluz O, Huober J, Kreipe HH, Kates RE, Hartmann A, Erber R, Scholz M, Lisboa B, Mohrmann S, Möbus V, Augustin D, Hoffmann G, Weiss E, Böhmer S, Kreienberg R, Du Bois A, Sattler D, Thomssen C, Kiechle M, Jänicke F, Wallwiener D, Harbeck N, Kuhn W.

Ann Oncol. 2014 Aug;25(8):1551-7. doi: 10.1093/annonc/mdu186. Epub 2014 May 14.

17.
18.

Sentinel node biopsy and axillary dissection in breast cancer: the evidence and its limits.

Janni W, Kühn T, Schwentner L, Kreienberg R, Fehm T, Wöckel A.

Dtsch Arztebl Int. 2014 Apr 4;111(14):244-9. doi: 10.3238/arztebl.2014.0244. Review.

19.

The impact of educational materials on compliance and persistence rates with adjuvant aromatase inhibitor treatment: first-year results from the compliance of aromatase inhibitors assessment in daily practice through educational approach (CARIATIDE) study.

Neven P, Markopoulos C, Tanner M, Marty M, Kreienberg R, Atkins L, Franquet A, Gnant M, Neciosup S, Tesarova P, Barni S, Deschamp V.

Breast. 2014 Aug;23(4):393-9. doi: 10.1016/j.breast.2014.02.009. Epub 2014 Mar 24.

PMID:
24675394
20.

Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.

EBCTCG (Early Breast Cancer Trialists' Collaborative Group), McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, Gray R, Mannu G, Peto R, Whelan T, Wang Y, Wang Z, Darby S.

Lancet. 2014 Jun 21;383(9935):2127-35. doi: 10.1016/S0140-6736(14)60488-8. Epub 2014 Mar 19. Erratum in: Lancet. 2014 Nov 22;384(9957):1848.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk